Nadine Rouphael, MD
Enriched profileSumner E. Thompson, III Distinguished Professor of Vaccinology and Infectious Diseases; Professor, Division of Infectious Diseases, Department of Medicine · Emory University School of Medicine
Nadine Rouphael is Sumner E. Thompson, III Distinguished Professor of Vaccinology and Infectious Diseases; Professor, Division of Infectious Diseases, Department of Medicine at Emory University School of Medicine. OpenAlex indexes 376 publications with 26,424 citations (h-index 62); ClinicalTrials.gov lists 23 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Nadine Rouphael, MD, is Sumner E. Thompson, III Distinguished Professor of Vaccinology and Infectious Diseases at Emory University School of Medicine, Atlanta, GA. The public record shows 376 publications with 26,424 citations (h-index 62), centered on SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Influenza Virus Research Studies. It also documents an investigator role on 23 registered clinical trials, industry payments reported by 6 companies, 7 NIH-funded awards (2018–2026).
- Most recent indexed publication: 2026 · Science translational medicine
- Top research focus: SARS-CoV-2 and COVID-19 Research
- 23 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 53 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 187.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 23 registered studies on ClinicalTrials.gov. The most recent:
Industry payments
Updated 27 Aug 2026
6 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20257 payments
- ModernaTX, Inc.Program year20247 payments
- Seqirus USA IncProgram year20241 payment
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Lipopeptide Antibacterial100%Daptomycin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
7 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Clinical Core: Drivers of influenza A virus transmission in humans
Emory University
FY2026$412,115P01AI186819
Congress activity
Updated 27 Aug 2026
2 congress contributions (2021–2023) across ASTRO per OpenAlex. The most recent:
- Reduced Intubation Rates Following Whole-Lung Low-Dose Radiation Therapy (LD-RT) in Patients With COVID-19-Related Pneumonia
ASTRO Annual Meeting
ASTRO2021Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- SARS-CoV-2 variant booster vaccination and infection alter the breadth of the memory B cell repertoire.
Science translational medicine
Article2026 - Zoster Vaccination and Dementia: Interpreting the Signal and Testing the Mechanisms.
Clinical infectious diseases
Article2026 - Feasibility and Safety of Aerosolized Influenza Virus Challenge in Humans Using Two Modern Delivery Systems.
The Journal of infectious diseases
Article2026 - Improved VSV-Ebola-GP booster vaccination approach promotes antibody affinity maturation and durable anti-Ebola immunity in humans.
Nature immunology
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)- 01An mRNA Vaccine against SARS-CoV-2 — Preliminary ReportArticle3,490 citations2020
- 02Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19Article1,924 citations2020
- 03Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsArticle1,633 citations2020
- 04Systems biological assessment of immunity to mild versus severe COVID-19 infection in humansArticle1,345 citations2020
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/nadine-rouphael-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/nadine-rouphael-34355116
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
hopeclinic.emory.edu/about/bios/rouphael-nadine.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopeclinic.emory.edu ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/EmoryDeptofMed/posts/dom-faculty-news-please-join-us-in-congratulating-nadine-rouphael-md-infectious-/935580698572723
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
georgiactsa.org/news-events/news/2024/discovery/rouphael-acsi/index.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →georgiactsa.org ↗ - X / Twitter
X/Twitter: @Rouphael_N
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaccines.emory.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaccines.emory.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaccines.emory.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopeclinic.emory.edu ↗
- Fellow
American Society for Clinical Investigation (FASCI)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →data.the-asci.org ↗ - Fellow
Infectious Diseases Society of America (FIDSA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopeclinic.emory.edu ↗ - Fellow
Society for Clinical and Translational Science / Southern Society for Clinical Investigation (FSSCI)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hopeclinic.emory.edu ↗
Editorial & leadership roles
journal and society appointments- Associate Editor
Clinical Infectious Diseases (Vaccine section)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaccines.emory.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →idsociety.org ↗
Secondary affiliations
appointments beyond the home institution- Executive Director
Hope Clinic (clinical arm of the Emory Vaccine Center)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaccines.emory.edu ↗ - Investigator
Emory Center for AIDS Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaccines.emory.edu ↗ - Principal Investigator
NIH-funded Vaccine and Treatment Evaluation Unit (VTEU), Emory
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaccines.emory.edu ↗
Media & interviews
press, podcasts and appearances- Georgia Public Broadcasting news feature
quoted as interim director of Hope Clinic on Moderna COVID-19 vaccine trial results
2020 - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →idcrc.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Arshed Quyyumi, MD
Emory University School of Medicine
Guillermo Umpierrez, MD
Emory University School of Medicine
Stewart Factor, DO
Emory University School of Medicine
Nabil Saba, MD
Emory University School of Medicine